Johnson & Johnson Aktie
WKN: 853260 / ISIN: US4781601046
16.07.2025 13:01:20
|
Johnson & Johnson Q2 Profit Increases, Beats Estimates
(RTTNews) - Johnson & Johnson (JNJ) announced a profit for its second quarter that Increased from the same period last year and beat the Street estimates.
The company's earnings totaled $5.537 billion, or $2.29 per share. This compares with $4.686 billion, or $1.93 per share, last year.
Excluding items, Johnson & Johnson reported adjusted earnings of $6.699 billion or $2.77 per share for the period.
Analysts on average had expected the company to earn $2.68 per share. Analysts' estimates typically exclude special items.
The company's revenue for the period rose 5.8% to $23.743 billion from $22.447 billion last year.
Johnson & Johnson earnings at a glance (GAAP) :
-Earnings: $5.537 Bln. vs. $4.686 Bln. last year. -EPS: $2.29 vs. $1.93 last year. -Revenue: $23.743 Bln vs. $22.447 Bln last year.
Looking ahead, citing strong operational performance and favorable foreign exchange, Johnson & Johnson has revised up its annual outlook.
The company now expects annual adjusted income per share of $10.80 to $10.90, higher than the earlier outlook of $10.50 to $10.70 per share. This revised outlook reflects a year-on-year growth of 8.2% to 9.2%.
For the full year, adjusted operational income per share is now projected to be $10.63 to $10.73 as against the earlier guidance of $10.50 to $10.70 per share. This revised guidance reflects a growth of 6.5% to 7.5% from last year.
JNJ now projects full-year reported sales of $93.2 billion to $93.6 billion, compared with the prior expectation of $91 billion to $91.8 billion. This revised guidance reflects a growth of 5.1% to 5.6% from last year.
Analysts, on average, forecast the company to report income of $10.61 per share on revenue of $91.33 billion for the full year.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Johnson & Johnsonmehr Nachrichten
20:05 |
Minuszeichen in New York: Dow Jones schwächelt nachmittags (finanzen.at) | |
26.09.25 |
Optimismus in New York: Dow Jones zum Ende des Freitagshandels mit Zuschlägen (finanzen.at) | |
25.09.25 |
Handel in New York: Dow Jones beendet den Handel mit Verlusten (finanzen.at) | |
25.09.25 |
Dow Jones aktuell: Dow Jones gibt zum Start des Donnerstagshandels nach (finanzen.at) | |
24.09.25 |
Dow Jones 30 Industrial-Papier Johnson Johnson-Aktie: So viel Gewinn hätte eine Investition in Johnson Johnson von vor einem Jahr abgeworfen (finanzen.at) | |
23.09.25 |
Dow Jones-Handel aktuell: Dow Jones sackt zum Ende des Dienstagshandels ab (finanzen.at) | |
23.09.25 |
Verluste in New York: Dow Jones präsentiert sich am Nachmittag schwächer (finanzen.at) | |
23.09.25 |
Dow Jones-Handel aktuell: Dow Jones am Dienstagmittag im Aufwind (finanzen.at) |
Analysen zu Johnson & Johnsonmehr Analysen
Aktien in diesem Artikel
Johnson & Johnson | 154,44 | 0,68% |
|